ArticleJournal of neuro-oncology2018

Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.

Vaios Hatzoglou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.